Roughly 30,000 Americans are diagnosed with multiple myeloma each year—a rare but serious cancer of the plasma cells. Historically treated with chemotherapy, patients often faced recurring disease and…
Kidney cancer affects over 80,000 Americans annually, with renal cell carcinoma as the dominant type. Benjamin R. Lee, MD, MBA, outlines current AUA guideline recommendations, including when to…
Learn about key symptoms of renal cell carcinoma such as hematuria (blood in the urine), flank pain, and a palpable mass, as well as less common symptoms like…
Learn how the immune system defends against foreign substances and what happens when it overreacts, causing allergies. This video explains the role of antigens, antibodies, and the types…
Join Elisa K. Boden, MD, Ryan Ungaro, MD, and patient advocate Nathan Marohn in this insightful social media event, “The Intersection of Histologic, Endoscopic, and Symptomatic Remission in…
Learn about Interventional Pulmonology and Thoracic Oncology with Scott Oh, MD, an Interventional Pulmonologist at UCLA and a Professor of Medicine at the David Geffen School of Medicine.…
Learn from Diana Girnita, MD about the early signs of rheumatoid arthritis (RA), an autoimmune disease where the body’s immune system attacks its own tissues, primarily affecting the…
Dive into the essentials of renal cell carcinoma, a significant type of kidney cancer. Learn about its presentation, diagnosis, and treatment options. This video covers the importance of…
Dr. Tahseen Mozaffar, clinical professor of neurology at the University of California Irvine, presents a webinar on Pompe Disease. Learn about the latest advancements in diagnosis, treatment options,…
Explore the atypical signs and symptoms of lung cancer, including the rare paraneoplastic syndromes caused by the disease. Learn about small cell carcinoma’s manifestations like Lambert-Eaton myasthenic syndrome,…
Multiple Myeloma is a cancer that affects plasma cells in bone marrow. Abnormal plasma cells produce harmful proteins, leading to anemia, bone pain, frequent infections, and kidney failure.…
A groundbreaking trial in the UK is testing the world’s first “personalized” mRNA vaccine against the deadliest form of skin cancer, melanoma. This innovative vaccine is tailored to…
